BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35925442)

  • 21. The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT.
    Monaco L; De Bernardi E; Bono F; Cortinovis D; Crivellaro C; Elisei F; L'Imperio V; Landoni C; Mathoux G; Musarra M; Pagni F; Turolla EA; Messa C; Guerra L
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3401-3411. PubMed ID: 35403860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of [
    Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
    Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
    Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
    Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
    Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of
    Zhang M; Bao Y; Rui W; Shangguan C; Liu J; Xu J; Lin X; Zhang M; Huang X; Zhou Y; Qu Q; Meng H; Qian D; Li B
    Front Oncol; 2020; 10():568857. PubMed ID: 33134170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of baseline
    Faudemer J; Aide N; Gac AC; Damaj G; Vilque JP; Lasnon C
    Sci Rep; 2021 Dec; 11(1):23812. PubMed ID: 34893676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.
    Shen H; Chen L; Liu K; Zhao K; Li J; Yu L; Ye H; Zhu W
    Quant Imaging Med Surg; 2021 Jul; 11(7):2918-2932. PubMed ID: 34249623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative classification and radiomics of [
    de Koster EJ; Noortman WA; Mostert JM; Booij J; Brouwer CB; de Keizer B; de Klerk JMH; Oyen WJG; van Velden FHP; de Geus-Oei LF; Vriens D;
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2174-2188. PubMed ID: 35138444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline
    Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
    Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics analysis of [
    Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Habitat Imaging-Based
    Chen L; Liu K; Zhao X; Shen H; Zhao K; Zhu W
    Front Oncol; 2021; 11():759897. PubMed ID: 34692548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiomics Analysis of [
    Ceriani L; Milan L; Virili C; Cascione L; Paone G; Trimboli P; Giovanella L
    Thyroid; 2021 Jan; 31(1):88-95. PubMed ID: 32517585
    [No Abstract]   [Full Text] [Related]  

  • 33. Integrated CT Radiomics Features Could Enhance the Efficacy of
    Zhou W; Huang Q; Wen J; Li M; Zhu Y; Liu Y; Dai Y; Guan Y; Zhou Z; Hua T
    Front Oncol; 2021; 11():772703. PubMed ID: 34869011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [
    Noortman WA; Vriens D; de Geus-Oei LF; Slump CH; Aarntzen EH; van Berkel A; Timmers HJLM; van Velden FHP
    Eur Radiol; 2022 Oct; 32(10):7227-7236. PubMed ID: 36001126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [
    de Jesus FM; Yin Y; Mantzorou-Kyriaki E; Kahle XU; de Haas RJ; Yakar D; Glaudemans AWJM; Noordzij W; Kwee TC; Nijland M
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1535-1543. PubMed ID: 34850248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition.
    Basler L; Gabryś HS; Hogan SA; Pavic M; Bogowicz M; Vuong D; Tanadini-Lang S; Förster R; Kudura K; Huellner MW; Dummer R; Guckenberger M; Levesque MP
    Clin Cancer Res; 2020 Aug; 26(16):4414-4425. PubMed ID: 32253232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of
    Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
    Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hybrid few-shot multiple-instance learning model predicting the aggressiveness of lymphoma in PET/CT images.
    Xu C; Feng J; Yue Y; Cheng W; He D; Qi S; Zhang G
    Comput Methods Programs Biomed; 2024 Jan; 243():107872. PubMed ID: 37922655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
    Huang B; Sollee J; Luo YH; Reddy A; Zhong Z; Wu J; Mammarappallil J; Healey T; Cheng G; Azzoli C; Korogodsky D; Zhang P; Feng X; Li J; Yang L; Jiao Z; Bai HX
    EBioMedicine; 2022 Aug; 82():104127. PubMed ID: 35810561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [
    Ferreira M; Lovinfosse P; Hermesse J; Decuypere M; Rousseau C; Lucia F; Schick U; Reinhold C; Robin P; Hatt M; Visvikis D; Bernard C; Leijenaar RTH; Kridelka F; Lambin P; Meyer PE; Hustinx R
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3432-3443. PubMed ID: 33772334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.